Back to today’s briefing

Story perspectives

New Blood Test Reveals 77% Accuracy for ME/CFS Diagnosis

8/14/2025

31 7

Summary

Story summary

Groundbreaking research uncovers a 21-gene signature in blood plasma, offering a promising 77% accuracy in diagnosing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Coupled with insights from gut microbiome analysis, these discoveries could revolutionize the understanding and treatment of the 4.3 million Americans grappling with this debilitating condition.

1 of 1

Story summary

Groundbreaking research uncovers a 21-gene signature in blood plasma, offering a promising 77% accuracy in diagnosing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Coupled with insights from gut microbiome analysis, these discoveries could revolutionize the understanding and treatment of the 4.3 million Americans grappling with this debilitating condition.